Advertisement
Loading...

ANI Pharmaceuticals, Inc.

ANIP•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$78.01
$-1.57(-1.97%)
U.S. Market opens in 28h 26m

ANI Pharmaceuticals, Inc. (ANIP) Stock Overview

Explore ANI Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio18.24
EPS (TTM)$3.91
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$85.45
3 Months$91.45
1 Year Target$93.37

ANIP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ANI Pharmaceuticals, Inc. (ANIP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $93.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.24 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.97%
5-Day Change
-11.11%
1-Month Change
2.001%
3-Month Change
0.84%
6-Month Change
-7.15%
Year-to-Date (YTD) Change
-1.18%
1-Year Change
31.04%
3-Year Change
90.83%
5-Year Change
112.10%
All-Time (Max) Change
-63.50%

Contact Information

https://www.anipharmaceuticals.com
218 634 3500
210 Main Street West, Baudette, MN, 56623

Company Facts

897 Employees
IPO DateMay 5, 2000
CountryUS
Actively Trading

Frequently Asked Questions